US Health Authorities have recommended that the use of the Johnson & Johnson COVID-19 vaccine be paused. Editor's note: This Livestream has ended. You may watch the recording above. Courtesy #DStv403 #eNCA JOHANNESBURG - Health Minister Zweli Mkhize will make an announcement on South Africa's response in consideration of the FDA's decision to advise on the temporary suspension of the Johnson & Johnson vaccine in the United States. This, over concern over potential links to a rare type of blood clot. The disorder appears similar to that observed in rare cases of people who were vaccinated using the AstraZeneca jab. READ:Â US regulators recommend 'pause' in use of J&J vaccine over blood clot fears The cases involving the J&J vaccine affected women between the ages of 18 and 48. Symptoms occurred six to 14 days after vaccination. The South African Health Ministry says it's looking into this.